Cargando…
A Perspective on Imiquimod Microneedles for Treating Warts
Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146107/ https://www.ncbi.nlm.nih.gov/pubmed/33922157 http://dx.doi.org/10.3390/pharmaceutics13050607 |
_version_ | 1783697323498405888 |
---|---|
author | Chiu, Tsu-Man Hsu, Ping-Chun Khan, Mohd Yaqub Lin, Cheng-An J. Lee, Chun-Hung Hsu, Tsai-Ching Chen, Min-Hua Hanagata, Nobutaka |
author_facet | Chiu, Tsu-Man Hsu, Ping-Chun Khan, Mohd Yaqub Lin, Cheng-An J. Lee, Chun-Hung Hsu, Tsai-Ching Chen, Min-Hua Hanagata, Nobutaka |
author_sort | Chiu, Tsu-Man |
collection | PubMed |
description | Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a synthetic compound that belongs to the imidazoquinolinone family. It has been successfully used as a topical drug to treat external anogenital warts. However, topical imiquimod cream for warts is restricted by low skin permeability, and several side effects such as itching, pain, and erosions occur most frequently following topical treatment. Microneedle technology, a minimally invasive drug delivery system, has the potential to overcome the barrier of the stratum corneum. This technique would also offer a painless treatment choice and provide personalized therapies. In the study, we loaded imiquimod within dissolving microneedles using the molding method. Gelatin was used as a structural material for microneedle formation without adding a crosslinker. To our knowledge, this is the first study of using dissolving microneedles and exploring their utilization with imiquimod for the treatment of warts. First, we added fluorescent dye and trypan blue into the microneedles to evaluate the status of drugs in the microneedles and the degradation property of microneedles made of gelatin, respectively. Here we also prove the strength of the imiquimod microneedles and study their capability to penetrate the skin. The results show no apparent differences in mechanical failure after an additional imiquimod-loaded. Besides, we provide evidence that imiquimod microneedles induce secreted embryonic alkaline phosphatase (SEAP) in the RAW 264.7 macrophages. Gelatin does not affect the imiquimod in microneedles; a similar immune response was affected by the imiquimod alone or imiquimod complexed with gelatin. Our research demonstrates a proof of concept of using imiquimod microneedles for future warts treatment. |
format | Online Article Text |
id | pubmed-8146107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81461072021-05-26 A Perspective on Imiquimod Microneedles for Treating Warts Chiu, Tsu-Man Hsu, Ping-Chun Khan, Mohd Yaqub Lin, Cheng-An J. Lee, Chun-Hung Hsu, Tsai-Ching Chen, Min-Hua Hanagata, Nobutaka Pharmaceutics Perspective Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a synthetic compound that belongs to the imidazoquinolinone family. It has been successfully used as a topical drug to treat external anogenital warts. However, topical imiquimod cream for warts is restricted by low skin permeability, and several side effects such as itching, pain, and erosions occur most frequently following topical treatment. Microneedle technology, a minimally invasive drug delivery system, has the potential to overcome the barrier of the stratum corneum. This technique would also offer a painless treatment choice and provide personalized therapies. In the study, we loaded imiquimod within dissolving microneedles using the molding method. Gelatin was used as a structural material for microneedle formation without adding a crosslinker. To our knowledge, this is the first study of using dissolving microneedles and exploring their utilization with imiquimod for the treatment of warts. First, we added fluorescent dye and trypan blue into the microneedles to evaluate the status of drugs in the microneedles and the degradation property of microneedles made of gelatin, respectively. Here we also prove the strength of the imiquimod microneedles and study their capability to penetrate the skin. The results show no apparent differences in mechanical failure after an additional imiquimod-loaded. Besides, we provide evidence that imiquimod microneedles induce secreted embryonic alkaline phosphatase (SEAP) in the RAW 264.7 macrophages. Gelatin does not affect the imiquimod in microneedles; a similar immune response was affected by the imiquimod alone or imiquimod complexed with gelatin. Our research demonstrates a proof of concept of using imiquimod microneedles for future warts treatment. MDPI 2021-04-22 /pmc/articles/PMC8146107/ /pubmed/33922157 http://dx.doi.org/10.3390/pharmaceutics13050607 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Chiu, Tsu-Man Hsu, Ping-Chun Khan, Mohd Yaqub Lin, Cheng-An J. Lee, Chun-Hung Hsu, Tsai-Ching Chen, Min-Hua Hanagata, Nobutaka A Perspective on Imiquimod Microneedles for Treating Warts |
title | A Perspective on Imiquimod Microneedles for Treating Warts |
title_full | A Perspective on Imiquimod Microneedles for Treating Warts |
title_fullStr | A Perspective on Imiquimod Microneedles for Treating Warts |
title_full_unstemmed | A Perspective on Imiquimod Microneedles for Treating Warts |
title_short | A Perspective on Imiquimod Microneedles for Treating Warts |
title_sort | perspective on imiquimod microneedles for treating warts |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146107/ https://www.ncbi.nlm.nih.gov/pubmed/33922157 http://dx.doi.org/10.3390/pharmaceutics13050607 |
work_keys_str_mv | AT chiutsuman aperspectiveonimiquimodmicroneedlesfortreatingwarts AT hsupingchun aperspectiveonimiquimodmicroneedlesfortreatingwarts AT khanmohdyaqub aperspectiveonimiquimodmicroneedlesfortreatingwarts AT linchenganj aperspectiveonimiquimodmicroneedlesfortreatingwarts AT leechunhung aperspectiveonimiquimodmicroneedlesfortreatingwarts AT hsutsaiching aperspectiveonimiquimodmicroneedlesfortreatingwarts AT chenminhua aperspectiveonimiquimodmicroneedlesfortreatingwarts AT hanagatanobutaka aperspectiveonimiquimodmicroneedlesfortreatingwarts AT chiutsuman perspectiveonimiquimodmicroneedlesfortreatingwarts AT hsupingchun perspectiveonimiquimodmicroneedlesfortreatingwarts AT khanmohdyaqub perspectiveonimiquimodmicroneedlesfortreatingwarts AT linchenganj perspectiveonimiquimodmicroneedlesfortreatingwarts AT leechunhung perspectiveonimiquimodmicroneedlesfortreatingwarts AT hsutsaiching perspectiveonimiquimodmicroneedlesfortreatingwarts AT chenminhua perspectiveonimiquimodmicroneedlesfortreatingwarts AT hanagatanobutaka perspectiveonimiquimodmicroneedlesfortreatingwarts |